Avita Medical s patented and proprietary collection and application technology provides innovative treatment solutions derived from the regenerative properties of a patients own skin. Our medical devices work by preparing a Regenerative Epithelial Suspension RES , an autologous suspension comprised of the patients own skin cells and wound healing factors that are necessary to regenerate natural healthy skin. This is then applied to the area to be treated. In all countries outside of Europe, our portfolio is marketed under the ReCell brand to promote skin healing in a wide range of applications including burns, chronic wounds and aesthetics. ReCell is TGA registered in Australia, and CFDA cleared in China. In the United States, ReCell is an investigational device limited by federal law to investigational use. In Europe, our portfolio of medical device products received CE mark approval as three tailored product presentations, with three individual brand names. ReCell is designed for the treatment of burns and plastic reconstructive procedures ReGenerCell has been formulated for chronic wounds including leg and foot ulcers and ReNovaCell is tailored for aesthetic applications including the restoration of pigmentation.
Quote | Avita Medical (OTCMKTS:AVMXY)
Last: | $ |
---|---|
Change Percent: | 9.13% |
Open: | $7.97 |
Close: | $7.89 |
High: | $8.05 |
Low: | $7.83 |
Volume: | 528,505 |
Last Trade Date Time: | 09/30/2019 04:57:56 pm |
News | Avita Medical (OTCMKTS:AVMXY)
Trading of American Depository Shares to begin under the ticker symbol “RCEL” on October 1st AVITA Medical (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, annou...
On June 14, 2019, I published " The Stem Cell Triple Play: 3 Companies With Great Value Drivers ". Given how out of favor the stem cell sector has been for many years, I was surprised by the massive interest that this article generated. Given this unexpected level of interest and some co...
Message Board Posts | Avita Medical (OTCMKTS:AVMXY)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Avita Medical Company Name:
AVMXY Stock Symbol:
OTCMKTS Market:
Trading of American Depository Shares to begin under the ticker symbol “RCEL” on October 1st AVITA Medical (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, annou...
Recent journal publications investigate the potential use of the RECELL System to treat multiple dermatological conditions AVITA Medical (ASX: AVH) (OTCQX: AVMXY), a regenerative medicine company focused on the development and commercialization of innovative therapies leveraging the he...
First RECELL System clinical trial in the U.S. focused on acute soft tissue injuries, defects, and reconstruction; study expected to commence within next 6 months AVITA Medical (ASX: AVH, OTCQX: AVMXY), a regenerative medicine company focused on the development and commercialization of...